COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials
Description
CONCLUSIONS: For individuals with mildly immunocompromising conditions, there is no evidence of differences in VE against symptomatic or severe COVID-19 compared to those with non-tempered immune systems in the four COVID-19 vaccine randomized
